Streetbeat News

Regulatory

MSFT

NVDA

SPY

The U.S. has imposed new restrictions on the export of advanced chips to China, which is expected to significantly impact China's AI sector. This move could affect several U.S.-listed companies and ETFs, including NVIDIA (NVDA), Microsoft (MSFT), and the SPDR S&P 500 ETF (SPY). The restrictions aim to curb China's technological advancements in AI by limiting access to critical hardware.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 3:02 pm

GTLB

A critical vulnerability (CVE-2024-5655) in GitLab's Community and Enterprise Editions allows attackers to run pipelines as any user. GitLab has released updates to address this and other high-severity issues. Users are urged to upgrade to the latest versions immediately.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 2:55 pm

VRSN

Advocates are urging the NTIA and DOJ to break VeriSign's monopoly power over domain names, citing concerns over market control and pricing. This could lead to regulatory actions impacting VeriSign's business operations.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 2:53 pm

TSLA

XPEV

Tesla's Full Self-Driving (FSD) technology is expected to face significant challenges in China due to the prevalence of e-scooters and complex road conditions, as highlighted by XPeng's head of autonomous driving. XPeng's smart driving capabilities have been successfully tested in various Chinese cities, and their upcoming XNGP version will integrate advanced technology for broader use cases.

Portfolio Pulse from Nabaparna Bhattacharya

June 27, 2024 | 2:43 pm

BNTX

PFE

Pfizer and BioNTech have received a positive opinion from the CHMP for their Omicron JN.1-adapted COVID-19 vaccine in the EU. The vaccine is recommended for individuals 6 months and older and is based on data showing improved immune response. Doses will be ready to ship upon authorization by the European Commission.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 2:31 pm

PRGO

SPY

The U.S. Supreme Court has allowed abortions to be performed in Idaho in cases of medical emergencies for pregnant women, at least for now.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 2:26 pm

MRK

The FDA has issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) of patritumab deruxtecan, a lung cancer drug developed by Daiichi Sankyo and Merck, due to issues at a third-party manufacturing facility. The CRL did not raise concerns about the drug's efficacy or safety. Merck's stock was down 1.04% following the news.

Portfolio Pulse from Vandana Singh

June 27, 2024 | 2:13 pm

SPY

The Supreme Court has limited the SEC's use of in-house judges in fraud cases, supporting the right to a jury trial for some SEC defendants. This decision could impact the SEC's enforcement capabilities and the broader regulatory environment.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 2:11 pm

SPY

The Supreme Court has rejected Purdue Pharma's proposed opioid settlement that included legal protections for the Sackler family. This decision could have significant implications for the company's bankruptcy proceedings and the broader pharmaceutical industry.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 2:06 pm

SPY

The Supreme Court has blocked the Environmental Protection Agency's (EPA) 'Good Neighbor' ozone rule, granting requests from companies and states challenging the regulation.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 2:02 pm